Lupin Ltd

NSE:LUPIN (India)   Ordinary Shares
₹ 1662.95 (+1.46%) May 16
38.44
P/B:
5.13
Market Cap:
₹ 757.37B ($ 9.09B)
Enterprise V:
₹ 759.70B ($ 9.11B)
Volume:
1.34M
Avg Vol (2M):
1.07M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Lupin Ltd ( ) from 2001 to May 17 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Lupin stock (NSE:LUPIN) PE ratio as of May 17 2024 is 38.44. More Details

Lupin Ltd (NSE:LUPIN) PE Ratio (TTM) Chart

To

Lupin Ltd (NSE:LUPIN) PE Ratio (TTM) Historical Data

Total 1279
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Lupin PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-17 39.7 2024-03-15 41.8
2024-05-16 39.7 2024-03-14 42.1
2024-05-15 39.1 2024-03-13 40.9
2024-05-14 39.1 2024-03-12 42.0
2024-05-13 40.3 2024-03-11 42.8
2024-05-10 38.4 2024-03-08 42.6
2024-05-09 37.8 2024-03-07 42.6
2024-05-08 38.6 2024-03-06 42.5
2024-05-07 38.5 2024-03-05 42.8
2024-05-06 40.1 2024-03-04 42.6
2024-05-03 39.5 2024-03-01 41.5
2024-05-02 39.3 2024-02-29 41.4
2024-05-01 39.3 2024-02-28 41.2
2024-04-30 39.3 2024-02-27 41.4
2024-04-29 39.1 2024-02-26 41.0
2024-04-26 38.6 2024-02-23 41.2
2024-04-25 38.1 2024-02-22 40.7
2024-04-24 37.7 2024-02-21 40.8
2024-04-23 37.7 2024-02-20 40.5
2024-04-22 38.3 2024-02-19 40.5
2024-04-19 37.0 2024-02-16 41.4
2024-04-18 38.1 2024-02-15 41.0
2024-04-17 38.5 2024-02-14 41.1
2024-04-16 38.5 2024-02-13 41.0
2024-04-15 38.4 2024-02-12 40.7
2024-04-12 38.7 2024-02-09 41.4
2024-04-11 38.3 2024-02-08 41.0
2024-04-10 38.3 2024-02-07 40.7
2024-04-09 38.3 2024-02-06 40.3
2024-04-08 38.5 2024-02-05 40.1
2024-04-05 38.2 2024-02-02 38.4
2024-04-04 37.9 2024-02-01 38.6
2024-04-03 38.3 2024-01-31 38.4
2024-04-02 38.4 2024-01-30 37.5
2024-04-01 38.8 2024-01-29 37.9
2024-03-29 38.6 2024-01-26 37.1
2024-03-28 38.6 2024-01-25 37.1
2024-03-27 40.8 2024-01-24 37.0
2024-03-26 41.2 2024-01-23 36.7
2024-03-25 41.0 2024-01-22 36.5
2024-03-22 41.0 2024-01-19 36.5
2024-03-21 41.1 2024-01-18 36.4
2024-03-20 39.9 2024-01-17 35.7
2024-03-19 40.1 2024-01-16 35.4
2024-03-18 41.2 2024-01-15 36.1

Lupin Ltd (NSE:LUPIN) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Lupin Ltd is a specialty and generic drug manufacturing company. The company's global formulations business develops and delivers a wide range of branded and generic formulations across the globe. The operations of the company are limited to one segment, namely pharmaceuticals and related products. The company also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India.